NCT00817401

Brief Summary

Perinatal asphyxia-induced brain injury is one of the most common causes of morbidity and mortality in term and preterm neonates. Birth asphyxia accounts for 23% of neonatal deaths globally and survivors suffer from long term neurological disability and impairment. Although many neuroprotective strategies appeared promising in animal models, most of them were not feasible and effective in human newborns. However, hypothermia was reported not to be effective if introduced beyond and thus should be introduced within 6 hrs after birth.Applying this selection criterion naturally would deprive many patients of the opportunity of hypothermia treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Jul 2002

Longer than P75 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2002

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2008

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

January 2, 2009

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 6, 2009

Completed
Last Updated

January 6, 2009

Status Verified

January 1, 2009

Enrollment Period

5.9 years

First QC Date

January 2, 2009

Last Update Submit

January 5, 2009

Conditions

Keywords

asphyxiahypothermiahypoxic-ischemic encephalopathyneonates

Outcome Measures

Primary Outcomes (1)

  • Mortality and disability rate.

    18 months

Interventions

For the systemic hypothermia treatment (TS Med 200, Germany), the infants were nursed under an open unit, covered only by a diaper and a thin linen, loosing heat to the environment and to a cooling mat¬tress which was perfused by circulating liquid at a variable temperature. The rectal temperature was targeted at 33.5 °C (range of 33 to 34 °C) and was meant to be achieved within 60 min. The body temperature was checked every 10 min during induction hypothermia and every hour during the remaining period of cooling. The duration of hypothermia was 72 hrs. Rewarming was started by stopping the cooling system. The infant was meant to reach a 36.5°C rectal temperature in 6 hrs after stopping cooling to prevent rebound hyperthermia.

Also known as: TS Med 200, Germany

Eligibility Criteria

Age1 Hour - 10 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Gestation age ≥37 weeks and body weight \>2500g.
  • with one of the following factors:
  • Apgar score\<5 at 5min;
  • Assisted respiration \>3min due to respiratory distress;
  • pH≤7.1 of cord or arterial blood within 60min after birth;
  • clinical manifestation of encephalopathy during the first 10 hrs of life.

You may not qualify if:

  • Major congenital abnormalities;
  • Head trauma or skull fracture causing major intracranial hemorrhage;
  • Mild HIE;
  • Financial problems of the parents;
  • Lack of permanent address;
  • Postnatal age \> 10 hrs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NICU, the Third Affiliated Hospital, Zhengzhou University

Zhengzhou, Henan, 450052, China

Location

MeSH Terms

Conditions

Hypoxia-Ischemia, BrainAsphyxiaHypothermia

Condition Hierarchy (Ancestors)

Brain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesHypoxia, BrainVascular DiseasesCardiovascular DiseasesHypoxiaSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsDeathPathologic ProcessesWounds and InjuriesBody Temperature Changes

Study Officials

  • Changlian Zhu, MD, PhD

    Zhengzhou University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 2, 2009

First Posted

January 6, 2009

Study Start

July 1, 2002

Primary Completion

June 1, 2008

Study Completion

June 1, 2008

Last Updated

January 6, 2009

Record last verified: 2009-01

Locations